| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 136,585 | 127,085 | 115,738 | 121,572 | | Cost of Revenue | 33,190 | 28,779 | 27,593 | 30,233 | | | Gross Profit | 103,395 | 98,306 | 88,145 | 91,339 | | | Operating Expenses | | Research Development | 14,531 | 14,637 | 13,314 | 14,424 | | Selling General and Administrative | 36,178 | 35,018 | 24,720 | 27,035 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 93 | 128 | 74 | 200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 52,593 | 48,523 | 50,037 | 49,680 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,509 | 1,336 | 1,123 | 1,167 | | Earnings Before Interest And Taxes | 54,102 | 49,859 | 51,160 | 50,847 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 54,102 | 49,859 | 51,160 | 50,847 | | Income Tax Expense | 7,022 | 7,969 | 6,586 | (5,745) | | Minority Interest | (18,506) |
-
|
-
| 33 | | | | Net Income From Continuing Ops | 47,080 | 41,890 | 44,574 | 56,625 | | | Non-recurring Events | | Discontinued Operations |
-
| 446 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,574 | 42,336 | 44,574 | 56,625 | | Preferred Stock And Other Adjustments | 8,780 | (8,801) | 21 |
-
| | | Net Income Applicable To Common Shares | $37,354 | $33,535 | $44,595 | $56,625 |
|
1.27% Nasdaq 
Income Statement
